Chronic and silent inflammation: How environmental factors and our lifestyle contribute to cancer, diabetes, cardiovascular and autoimmune diseases

The gut as the control centre of ‘silent inflammation’: the active ingredient PMA-zeolite plays an expanded role in regulating silent inflammation

Persistent silent inflammation, also known as chronic inflammation, is now regarded as one of the key triggers of our modern lifestyle diseases. Scientific research is increasingly showing that its development is linked to: Environmental pollutants such as heavy metals and countless toxins, poor diet, stress and the resulting disruption of the intestinal barrier, together with a damaged microbiome, can promote persistent inflammation throughout the body – and, as possible consequences, contribute to the development of cancer, diabetes, cardiovascular diseases, autoimmune diseases and also neurodegenerative diseases such as Alzheimer’s or Parkinson’s. Consequently, the gut – as the control centre of our immune system – and, with it, the active ingredient PMA zeolite are once again coming increasingly into focus in modern prevention and supportive therapy. But what is meant by silent inflammation, what role do the stresses of our modern environment play in its development, and what does all this have to do with the volcanic mineral PMA-zeolite, which has now demonstrated the full range of its mechanisms of action in over 50 clinical studies?

Chronic inflammation as a causal precursor to our lifestyle-related diseases

Silent inflammation refers to chronic, usually unnoticed inflammatory processes in the body in which the immune system remains permanently activated. Unlike acute inflammation, which our body initiates as a beneficial immune response to injuries or infections as a regulatory measure to promote healing, silent inflammation is extremely insidious, as we do not feel it for a long time or, initially, notice very little of it. They tend to manifest in a rather diffuse manner, initially through unexplained tiredness, mild fatigue, concentration problems, or wandering joint or muscle pain – yet all of this is, of course, non-specific and is often attributed to age, stress or ‘simply everyday life’.

Yet, inside the body, immunological processes are already taking place, often over years or even decades, which remain continuously active and, over time, begin to insidiously alter tissues, organs and metabolic processes. In the long term, they can have serious consequences and are therefore increasingly becoming the focus of research. For it is becoming increasingly clear that these silent inflammations are not merely side effects or interactions of diseases. Rather, they are triggers in their own right, ranking among the key drivers of our modern lifestyle diseases. At the same time, current research shows that silent inflammation is particularly closely linked to the condition of our gut, especially that of our gut barrier and our microbiome. It is therefore essential to address this very issue in both modern prevention and treatment – and the sooner, the better, by the way.

The body in a constant state of alarm: when inflammation no longer switches off

In principle, inflammation is not a bad thing. On the contrary: without inflammatory reactions, our body could not survive. They are part of our natural defence system. When bacteria, viruses or harmful substances enter the body, or when tissue is damaged, the immune system activates a wide range of defence mechanisms. Immune cells migrate into the tissue, pro-inflammatory messengers are released, pathogens are fought off and damaged structures are repaired. However, problems arise when this state of alarm does not come to an end.

Yet this is precisely what happens in cases of chronic or silent inflammation. The immune system remains permanently activated – not strong enough to trigger classic symptoms of inflammation such as high fever or severe pain, but sufficient to place the tissue under continuous stress. The body is, in a sense, in a state of permanent ‘smouldering fire’. The immune cells continue to produce pro-inflammatory messengers, oxidative stress increases, metabolic processes change, and tissues and organs begin to suffer long-term damage.

Environmental stressors: Underestimated accelerants of silent inflammation

Just a few decades ago, medicine focused heavily on genetic causes when it came to chronic diseases. Whilst genetic factors continue to play a role, modern research is showing ever more clearly that environmental and lifestyle factors have a far greater influence on the development of chronic diseases than was long assumed. In this context, one term is cropping up more and more frequently: the so-called exposome, which has shaped a new understanding of how diseases arise.

The term ‘exposome’ refers to the totality of all external stresses to which a person is exposed over the course of their life – these include air pollution, particulate matter, pesticides, microplastics, PFAS, heavy metals, the vast number of additives in our food, as well as the ever-present stress and lack of sleep and exercise. Quite apart from the fact that, from an evolutionary perspective, our organism has no defence against these stresses – which have only emerged in the last 50 years or so (how could our body possibly develop new defence strategies in such a short time?) – all these factors are fatally not acutely toxic, but act subtly through a “daily dose of poison”.

Environmental toxins prove particularly problematic, especially heavy metals such as cadmium, lead, mercury, arsenic and nickel, which were once bound in the earth’s layers as natural components of our planet but are now released through a wide variety of industrial processes and are toxic to the human body. These substances, which have long been found everywhere—in our air, water and food (as studies increasingly show, even in so-called ‘organic products’)—can trigger precisely those inflammatory processes that explain the rising prevalence of various lifestyle-related diseases. No part of our body is exempt from this: recent studies now even show links between metal exposure and chronic inflammatory processes in the gums (periodontitis) as well as accelerated biological ageing processes.

Added to this is our modern diet. Highly processed foods, large amounts of sugar, industrial fats and a low-fibre diet dramatically alter the gut environment and further promote silent inflammation. Researchers now suggest that the industrialised lifestyle as a whole creates an inflammation-promoting environment within the body, with the gut acting as the linchpin.

The intestinal barrier and the microbiome: silent inflammation begins in the gut

This comes as little surprise given what we now know about the gut. After all, the gut is far more than just a digestive tract, as was thought just a few decades ago. The gut is home to billions of microorganisms in the form of the microbiome, a large part of our immune system (previously estimated at 80 per cent, though recent studies are now suggesting the 90 per cent mark), and it is the highly complex, very sensitive gut barrier that determines which substances are allowed to enter the body – and which must remain outside. If this delicate balance between the microbiome, the mucous membrane and the intestinal barrier is disrupted, this can have far-reaching consequences.

This also explains the so-called ‘leaky gut’ phenomenon – increased permeability of the intestinal barrier – which is affecting more and more people and which, unsurprisingly, has only existed for a few decades. If the intestinal barrier is weakened, as is the case due to today’s environmental stresses, bacterial components, toxins and pro-inflammatory molecules can increasingly enter the bloodstream. The immune system responds to this with sustained activation and acts as an ideal driver for silent inflammation. Recent studies show just how closely the intestinal barrier actually works with immune cells, as intestinal macrophages actively influence the stability and repair processes of the intestinal wall. They are thus directly involved in regulating chronic inflammatory processes. This fundamentally changes our understanding of health.

Silent Inflammation and Cancer: When Inflammation Promotes Tumours

Particularly alarming is the now recognised link between silent inflammation and cancer. Cancer rates continue to rise, particularly among children and young people. Cancer has long been referred to as a ‘chronic disease’ that affects, or will affect, one in two Germans and one in two Austrians over the course of their lives. Consequently, an intensive search is underway for the causes, which lie quite elsewhere than previously thought.

How is it that this chronic inflammation promotes the development of cancer? Put simply, the following happens: the inflammation continuously produces aggressive oxygen compounds, known as ‘free radicals’, which cause oxidative stress. These processes, in turn, promote cell division and alter the structures of body tissues. This leads to the formation of new blood vessels that can supply developing tumours with nutrients. Our DNA is not spared by these processes either. Chronic inflammation increases the likelihood of genetic damage and can contribute to many abnormal cells – i.e. cancer cells – escaping the control of the immune system.

This link is particularly evident in chronic inflammatory bowel diseases such as Crohn’s disease or ulcerative colitis, from which millions of people suffer today – a figure that is also rising sharply. Those suffering from these autoimmune diseases have a significantly increased risk of bowel cancer. However, chronic inflammatory processes also play a central role in liver cancer, stomach cancer and certain types of lung cancer. Modern cancer research is therefore increasingly viewing inflammation not merely as a side effect, but as an active driver in tumour development.

Curbing silent inflammation or preventing it from arising in the first place has therefore become a key issue today, not only in cancer screening but also in general prevention and treatment. To detect the activation of chronic inflammation, doctors first measure the so-called CRP level (C-reactive protein) in the blood when inflammation is suspected. This indicates both acute and chronic inflammation and must therefore be repeated several times to distinguish acute from chronic inflammatory processes. This is the standard procedure. However, an increasing number of doctors are also paying attention to the burden on the gut caused by environmental toxins such as heavy metals, pesticides and other environmental toxins. And they almost always find something: there is hardly a patient with the symptoms of silent inflammation whose body does not contain significant amounts of environmental toxins. Experts therefore assume that testing for heavy metals and other toxins will increasingly become – or must become – standard practice in medical diagnostics. And once a diagnosis has been made, it is essential to immediately relieve, cleanse and regulate the gut – and this has been proven to work exceptionally well with the active ingredient PMA zeolite.

PMA zeolite: a toxin binder and essential health tool for today’s demands

PMA zeolite is a special form of zeolite. Zeolites are a group of so-called aluminosilicates of volcanic, i.e. natural, origin, consisting mainly of silicon and aluminium (which, incidentally, is not released into the body). However, only one form of these zeolites, known as clinoptilolite zeolite, is used in medicine. Zeolite per se has a porous, sponge-like structure, whose networks form a vast internal surface area: This internal surface area typically ranges between 30 and 50 square metres per gram (m²/g) of clinoptilolite zeolite and is now processed into the well-known active ingredient PMA zeolite through a special treatment and refinement process by the research and development company PANACEO in Austria (PMA stands for ‘patented micro-activation’). This zeolite even has an internal surface area of around 75 m²/g.

When taken in powder or capsule form, PMA zeolite can thus bind and eliminate a large quantity of harmful substances, particularly heavy metals, in the gut without placing any strain on the human body or interfering with its metabolism. As such, PMA zeolite represents a highly relevant tool in today’s world for minimising silent inflammation and thus acting as a fundamental building block of a healthy, unburdened body.

This, along with the associated relief and restoration of the gut—which in turn affects the health of the entire organism—has now been investigated and proven in over 50 clinical studies. These studies on efficacy and patient safety actually apply only to the specific PMA zeolite, which is accordingly a Class IIB authorised medical device – even though some suppliers of other zeolite products attempt to give the impression that these studies also apply to their zeolites (see also: Zeolite Studies). However, not all zeolites are the same, and one cannot ‘compare apples with pears’, which also applies to the studies.

This should be borne in mind before starting a detoxification and cleansing regimen with zeolite at home, and, if in doubt, seek advice from pharmacists and doctors.

The growing number of clinical studies on PMA zeolite and the medical urgency to develop new concepts in prevention and therapy in line with the demands of our time go hand in hand. Whilst detoxification treatments with zeolite were, as recently as 20 years ago, primarily a (centuries-old, incidentally) measure of naturopathy, PMA zeolite has long since become widely established in conventional medicine (see also: Zeolite and its role in medical treatment) and is increasingly being used in hospitals and clinics. As a key factor and an easy-to-implement measure for reducing chronic inflammatory processes, PMA zeolite now contributes more fundamentally than ever to the prevention of serious diseases.

Sources and literature: